Literature DB >> 21545503

Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis: a case series.

Ting-Shun Wang1, Tsen-Fang Tsai1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545503     DOI: 10.1111/j.1346-8138.2011.01224.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   3.468


× No keyword cloud information.
  6 in total

Review 1.  Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors:  Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Authors:  Yang Lo; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

3.  Erythrodermic Psoriasis Treated with Golimumab: A Case Report.

Authors:  Won-Ku Lee; Gun-Wook Kim; Hyun-Ho Cho; Won-Jeong Kim; Je-Ho Mun; Margaret Song; Hoon-Soo Kim; Hyun-Chang Ko; Moon-Bum Kim; Byung-Soo Kim
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

4.  Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.

Authors:  Rosita Saraceno; Marina Talamonti; Marco Galluzzo; Andrea Chiricozzi; Antonio Costanzo; Sergio Chimenti
Journal:  Case Rep Dermatol       Date:  2013-09-26

5.  Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases.

Authors:  Ye Seul Kim; Hyun Ju Kim; Sanghoon Lee; Young Lip Park
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

6.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.